(Reuters) - The group will begin a tender offer by June 14 to acquire all of Biomet's outstanding shares. At least 75 percent of the shares must favor the deal.
Biomet shares rose $1.37, or 3 percent, to $45.57 in morning trade on Nasdaq, close to the offer price, suggesting that investors think the deal has a good likelihood of shareholder acceptance.
Read more at Reuters.com Business News
Biomet shares rose $1.37, or 3 percent, to $45.57 in morning trade on Nasdaq, close to the offer price, suggesting that investors think the deal has a good likelihood of shareholder acceptance.
Read more at Reuters.com Business News
No comments:
Post a Comment